INAF
vs
J
Jakarta Composite Index
INAF
Over the past 12 months, INAF has underperformed Jakarta Composite Index, delivering a return of 0% compared to the Jakarta Composite Index's +14% growth.
Stocks Performance
INAF vs Jakarta Composite Index
Performance Gap
INAF vs Jakarta Composite Index
Performance By Year
INAF vs Jakarta Composite Index
Compare the stock's returns with its benchmark index and competitors. Gain insights into its relative performance over time.
Indofarma Tbk PT
Glance View
PT Indofarma Tbk is engaged in the pharmaceutical and healthcare businesses. The company is headquartered in Bekasi, Jawa Barat and currently employs 1,095 full-time employees. The company went IPO on 2001-04-17. The firm's business segment based on the products consists of the drug business segment and other medical equipment segment. The medical equipment segment consists of diagnostic and medical equipment. Its business segment based on geographical distribution area covers five regions consisting of Sumatra, Java, Kalimantan, Sulawesi and Bali, West Nusa Tenggara, and East Indonesia. Its products and services include generic drugs, over-the-counter and food, medical devices, non-medical devices and household health products. The firm carries out business activities to produce either alone or under cooperation for finished drug products, such as essential medicines, generic medicines with logos, generic medicines with trade names, traditional medicines, medical equipment, diagnostics, as well as food products, both related to health maintenance and improvement as well as health restoration.
